PSNC sets up Community Pharmacy Brexit Forum

PSNC sets up Community Pharmacy Brexit Forum

July 27 2018 Chief executives of representative bodies involved in community pharmacy and the...

Boots and PDA discuss union recognition, but no agreement as yet

Boots and PDA discuss union recognition, but no agreement as yet

July 26 2018 The Pharmacists’ Defence Association has been holding talks with members of...

Appeal process for overpayment recovery by NHS England to start in August

Appeal process for overpayment recovery by NHS England to start in August

July 26 2018 New regulations introducing an appeals process to challenge NHS England recovering...

MPs hear about community pharmacy role in LTC management

MPs hear about community pharmacy role in LTC management

July 20 2018 Community pharmacy representatives have briefed MPs about the role pharmacy teams...

MHRA launches consultation on implementing FMD safety features

MHRA launches consultation on implementing FMD safety features

July 20 2018 A consultation asking for views on how the safety features required under the...

  • PSNC sets up Community Pharmacy Brexit Forum

    PSNC sets up Community Pharmacy Brexit Forum

    Friday, 27 July 2018 16:04
  • Boots and PDA discuss union recognition, but no agreement as yet

    Boots and PDA discuss union recognition, but no agreement as yet

    Thursday, 26 July 2018 15:19
  • Appeal process for overpayment recovery by NHS England to start in August

    Appeal process for overpayment recovery by NHS England to start in August

    Thursday, 26 July 2018 15:04
  • MPs hear about community pharmacy role in LTC management

    MPs hear about community pharmacy role in LTC management

    Friday, 20 July 2018 16:30
  • MHRA launches consultation on implementing FMD safety features

    MHRA launches consultation on implementing FMD safety features

    Friday, 20 July 2018 14:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a pharmacist at computer imageJuly 20 2018

A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued.

The MHRA has launched the consultation with the FMD due to come into force from February 9 2019. The Directive requires all medicines to incorporate “safety features” which will involve:

  • a unique identifier (a 2D data matrix code and human readable information) that must be scanned at fixed points along the supply chain, including at the point of dispensing;
  • an anti-tampering device allowing verification of whether the packaging of a medicinal product has been tampered with.

The consultation papers include a number of questions as well as an impact assessment looking at proposed options for introducing the FMD system and what it might mean in financial and practical terms.

Among the issues where views are sought are:

  • what form of sanctions regime would be the most effective to enforce the regulations across the UK medicines supply chain?
  • is there any additional evidence or comment on the existing impact analysis to develop the cost benefit analysis in the impact assessment?
  • should manufacturers should be allowed to include information other than the unique identifier in the 2D data matrix code?

The consultation runs until September 23 2018.

The Royal Pharmaceutical Society has said it will be responding to this consultation and wants to hear members’ views on it. “If you would like to contribute to our response, please contact Aileen Bryson by 31 August,” it said. An email link is included in its announcement.

Links:
MHRA FMD consultation           
RPS comment   

Business News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...